Development and validation of a machine learning algorithm for predicting diffuse midline glioma, H3 K27-altered, H3 K27 wild-type high-grade glioma, and primary CNS lymphoma of the brain midline in adults
- PMID: 36681946
- DOI: 10.3171/2022.11.JNS221544
Development and validation of a machine learning algorithm for predicting diffuse midline glioma, H3 K27-altered, H3 K27 wild-type high-grade glioma, and primary CNS lymphoma of the brain midline in adults
Abstract
Objective: Preoperative diagnosis of diffuse midline glioma, H3 K27-altered (DMG-A) and midline high-grade glioma without H3 K27 alteration (DMG-W), as well as midline primary CNS lymphoma (PCNSL) in adults, is challenging but crucial. The aim of this study was to develop a model for predicting these three entities using machine learning (ML) algorithms.
Methods: Thirty-three patients with DMG-A, 35 with DMG-W, and 35 with midline PCNSL were retrospectively enrolled in the study. Radiomics features were extracted from contrast-enhanced T1-weighted MR images. Two radiologists evaluated the conventional MRI features of the tumors, such as shape. Patient age, tumor volume, and conventional MRI features were considered clinical features. The data set was randomly stratified into 70% training and 30% testing cohorts. Predictive models based on the clinical features, radiomics features, and integration of clinical and radiomics features were established through ML. The performances of the models were evaluated by calculating the area under the receiver operating characteristic curve, accuracy, sensitivity, and specificity. Subsequently, 10 patients with DMG-A, 10 with DMG-W, and 12 with PCNSL were enrolled from another institution to validate the established models.
Results: The predictive models based on clinical features, radiomics features, and the integration of clinical and radiomics features through the support vector machine algorithm had the optimal accuracies in the training, testing, and validation cohorts, and the accuracies in the testing cohort were 0.871, 0.892, and 0.903, respectively. Age, 2 radiomics features, and 3 conventional MRI features were the 6 most significant features in the established integrated model.
Conclusions: The integrated prediction model established by ML provides high discriminatory accuracy for predicting DMG-A, DMG-W, and midline PCNSL in adults.
Keywords: H3 K27–altered; adult; brain; glioma; lymphoma; magnetic resonance imaging; oncology.
Similar articles
-
Distinct MRI characteristics of spinal cord diffuse midline glioma, H3 K27-altered in comparison to spinal cord glioma without H3 K27-alteration and demyelination disorder.Acta Radiol. 2024 Mar;65(3):284-293. doi: 10.1177/02841851231215803. Epub 2023 Dec 20. Acta Radiol. 2024. PMID: 38115811
-
Automated Determination of the H3 K27-Altered Status in Spinal Cord Diffuse Midline Glioma by Radiomics Based on T2-Weighted MR Images.AJNR Am J Neuroradiol. 2023 Dec;44(12):1464-1470. doi: 10.3174/ajnr.A8056. AJNR Am J Neuroradiol. 2023. PMID: 38081676 Free PMC article. Clinical Trial.
-
Automated machine learning based on radiomics features predicts H3 K27M mutation in midline gliomas of the brain.Neuro Oncol. 2020 Mar 5;22(3):393-401. doi: 10.1093/neuonc/noz184. Neuro Oncol. 2020. PMID: 31563963 Free PMC article.
-
Adult diffuse midline gliomas H3 K27-altered: review of a redefined entity.J Neurooncol. 2022 Jul;158(3):369-378. doi: 10.1007/s11060-022-04024-5. Epub 2022 May 14. J Neurooncol. 2022. PMID: 35567713 Review.
-
Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies.Oncogene. 2022 Jan;41(4):461-475. doi: 10.1038/s41388-021-02102-y. Epub 2021 Nov 10. Oncogene. 2022. PMID: 34759345 Free PMC article. Review.
Cited by
-
Applications of artificial intelligence and advanced imaging in pediatric diffuse midline glioma.Neuro Oncol. 2025 Jul 30;27(6):1419-1433. doi: 10.1093/neuonc/noaf058. Neuro Oncol. 2025. PMID: 40037540 Free PMC article. Review.
-
Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors.Front Neurosci. 2023 May 5;17:1144559. doi: 10.3389/fnins.2023.1144559. eCollection 2023. Front Neurosci. 2023. PMID: 37214395 Free PMC article.
-
Radiomics for differentiation of gliomas from primary central nervous system lymphomas: a systematic review and meta-analysis.Front Oncol. 2024 Feb 14;14:1291861. doi: 10.3389/fonc.2024.1291861. eCollection 2024. Front Oncol. 2024. PMID: 38420015 Free PMC article.
-
-New frontiers in domain-inspired radiomics and radiogenomics: increasing role of molecular diagnostics in CNS tumor classification and grading following WHO CNS-5 updates.Cancer Imaging. 2024 Oct 7;24(1):133. doi: 10.1186/s40644-024-00769-6. Cancer Imaging. 2024. PMID: 39375809 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical